Poison pills aren’t medication — they’re one of the most powerful defenses a company has against hostile takeovers. When an aggressive buyer tries to snatch control, a well-designed poison pill can flip the script, raise the cost, and force everyone back to the negotiating table.

In this episode, we cover:
• What poison pills are and how they protect companies from hostile bidders
• How shareholder dilution makes takeovers more expensive—and often impossible
• The two major types: flip-in vs. flip-over (and why both pack a punch)
• When boards should deploy a poison pill—and the risks of doing it wrong
• Why timing, legal strategy, and board approval make or break this defense

Want to learn more? Explore our books at altfundsglobal.com/shop